These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15616316)

  • 41. Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit.
    Song W; Lee KM; Kim HS; Kim JS; Kim J; Jeong SH; Roh KH
    Int J Antimicrob Agents; 2006 Dec; 28(6):520-4. PubMed ID: 17095195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
    Doi Y; Wachino J; Ishiguro M; Kurokawa H; Yamane K; Shibata N; Shibayama K; Yokoyama K; Kato H; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2652-8. PubMed ID: 15215122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cephamycin resistance in clinical isolates and laboratory-derived strains of Escherichia coli, Nova Scotia, Canada.
    Clarke B; Hiltz M; Musgrave H; Forward KR
    Emerg Infect Dis; 2003 Oct; 9(10):1254-9. PubMed ID: 14609460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AmpC beta-lactamase producing multidrug resistant strains of Klebsiella spp. & Escherichia coli isolated from children under five in Chennai.
    Subha A; Devi VR; Ananthan S
    Indian J Med Res; 2003 Jan; 117():13-8. PubMed ID: 12866821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CMY-2 beta-lactamase-carrying community-acquired urinary tract Escherichia coli: genetic correlation with Salmonella enterica serotypes Choleraesuis and Typhimurium.
    Wu TL; Chia JH; Su LH; Chiu CH; Kuo AJ; Ma L; Siu LK
    Int J Antimicrob Agents; 2007 Apr; 29(4):410-6. PubMed ID: 17300921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The AmpC inhibitor, Syn2190, can be used to reveal extended-spectrum beta-lactamases in Escherichia coli.
    Netzel TC; Jindani I; Hanson N; Turner BM; Smith L; Rand KH
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):345-8. PubMed ID: 17379469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals.
    Yan JJ; Wu JJ; Ko WC; Tsai SH; Chuang CL; Wu HM; Lu YJ; Li JD
    J Antimicrob Chemother; 2004 Dec; 54(6):1007-12. PubMed ID: 15486082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae].
    Wang Y; Li ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):685-8. PubMed ID: 16255953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular mechanisms of cefoxitin resistance in Escherichia coli from the Toronto area hospitals.
    Forward KR; Willey BM; Low DE; McGeer A; Kapala MA; Kapala MM; Burrows LL
    Diagn Microbiol Infect Dis; 2001; 41(1-2):57-63. PubMed ID: 11687315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07.
    Rodríguez I; Barownick W; Helmuth R; Mendoza MC; Rodicio MR; Schroeter A; Guerra B
    J Antimicrob Chemother; 2009 Aug; 64(2):301-9. PubMed ID: 19474065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.
    Suzuki S; Shibata N; Yamane K; Wachino J; Ito K; Arakawa Y
    J Antimicrob Chemother; 2009 Jan; 63(1):72-9. PubMed ID: 19004839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of cefoxitin-resistant Escherichia coli isolates from recreational beaches and private drinking water in Canada between 2004 and 2006.
    Mataseje LF; Neumann N; Crago B; Baudry P; Zhanel GG; Louie M; Mulvey MR;
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3126-30. PubMed ID: 19398647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study on drug resistance of Pseudomonas aeruginosa plasmid-mediated AmpC β-lactamase.
    Zhu B; Zhang P; Huang Z; Yan HQ; Wu AH; Zhang GW; Mao Q
    Mol Med Rep; 2013 Feb; 7(2):664-8. PubMed ID: 23241821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular Characterization of Multidrug-Resistant
    Sadeghi M
    Microb Drug Resist; 2019 Nov; 25(9):1287-1296. PubMed ID: 31216231
    [No Abstract]   [Full Text] [Related]  

  • 56. Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak.
    Wendorf KA; Kay M; Baliga C; Weissman SJ; Gluck M; Verma P; D'Angeli M; Swoveland J; Kang MG; Eckmann K; Ross AS; Duchin J
    Infect Control Hosp Epidemiol; 2015 Jun; 36(6):634-42. PubMed ID: 25817743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment.
    Siu LK; Lu PL; Chen JY; Lin FM; Chang SC
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2138-44. PubMed ID: 12821459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of multiple cephalosporin-resistant Escherichia coli from a cattle fecal sample in Great Britain.
    Batchelor M; Clifton-Hadley FA; Stallwood AD; Paiba GA; Davies RH; Liebana E
    Microb Drug Resist; 2005; 11(1):58-61. PubMed ID: 15770096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CMY-29 and CMY-30, two novel plasmid-mediated AmpC beta-lactamases.
    Pope CE; Carter PE; Heffernan HM
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3178. PubMed ID: 19414570
    [No Abstract]   [Full Text] [Related]  

  • 60. A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins.
    Bauernfeind A; Wagner S; Jungwirth R; Schneider I; Meyer D
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2041-6. PubMed ID: 9303413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.